Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

exPDite-2: A Phase 3 Study to Assess the Efficacy and Safety of Midbrain Dopaminergic Neuronal Cell Therapy (Bemdaneprocel) for Patients With Parkinson's Disease (IRB 298952)


Collapse Overview 
Collapse sponsor award id
Protocol # BRT-DA01-301


Collapse Biography 

Collapse Time 
Collapse start date
2025-09-18

Collapse end date
2035-09-17